DROFEN's India representative completes technical visits to pharmaceutical manufacturers in Gujarat, reinforcing the company's localized service strategy for South Asia's booming injectable drug delivery market.
SHANGHAI, CHINA - May 2026 - DROFEN MACHINERY EQUIPMENT CO., LTD, a turnkey solution provider for injection pen and prefilled syringe assembly equipment, has announced that its India-based team has completed a series of on-site technical visits to pharmaceutical and medical device manufacturers across Gujarat, one of India's most dynamic pharmaceutical manufacturing regions.
The visits, led by Mr. Kaushik Dave, DROFEN's India Business Development Representative, included technical presentations on DROFEN's high-speed injection pen assembly capabilities and in-depth discussions with senior management and engineering teams at multiple facilities. The engagements received positive responses, with several companies expressing interest in further technical exchanges.
India's Injectable Market: A Strategic Priority
India's injectable drug delivery sector is expanding rapidly. The convergence of global GLP-1 demand, biosimilar insulin scale-up programs, and the Indian government's "Make in India" manufacturing initiative has created urgent demand for high-speed, validated assembly equipment. Gujarat, home to a dense cluster of pharmaceutical companies - including several publicly listed contract manufacturers specializing in precision plastic components and drug delivery devices - sits at the center of this growth wave.
"We have been watching the Indian market closely for some time, and what we see today confirms our decision to invest early," said Jordan Xu, Managing Director of DROFEN MACHINERY. "Gujarat alone has more injectable device manufacturing ambition than some entire countries. The conversations our team is having on the ground are substantive and forward-looking."
Why Localized Service Comes First
Mr. Xu emphasized that DROFEN's India strategy is built on a core conviction: without local presence, there is no real partnership.
"In our industry, selling a machine is the easy part. The hard part is everything that comes after - installation, commissioning, FAT, SAT, production ramp-up, and years of ongoing support. Our clients need someone who can be at their factory within hours, not days. Someone who understands Indian regulatory expectations, local utility standards, and the way business relationships are built here," said Jordan Xu.
"This is why we established a dedicated India team before we had a single Indian client. Mr. Kaushik Dave is not a sales agent working on commission - he is a full-time member of our organization who lives in India, understands the market, and is empowered to make decisions on the ground. As our India business grows, so will our local team. We are committed to being a local partner, not a distant supplier."
Mr. Kaushik Dave shared his perspective from the field: "Indian pharmaceutical companies are among the most technically demanding buyers I have worked with. They ask the right questions - about force control tolerances, data integrity under GAMP5, servo press repeatability, vision inspection reject logic. When I can answer those questions with real project data from our installed base, the conversation changes. It moves from 'who are you' to 'when can we start.'"
What DROFEN Brings to the Indian Market
DROFEN's offering for the Indian market is designed as a complete, turnkey package:
•Pre-assembly and final assembly lines for injection pen devices, with speeds ranging from 40 to 160 pens per minute
•Injection pen components sourced through China's established supply chain ecosystem, offered alongside the equipment
•Validation documentation including full IQ/OQ packages aligned with international GMP standards
•Localized after-sales support through the India-based team, covering commissioning, operator training, and ongoing technical service
"We don't just deliver equipment. We deliver the pen components, the validation documents, and the local support to help our clients get to market faster," added Jordan Xu. "For a CDMO entering the injection pen space for the first time, having a single-source partner who takes responsibility for the entire scope is a significant de-risking factor."
A Seller's Market - and DROFEN Is Ready
The global supply of validated, high-speed injection pen assembly equipment remains constrained. With only a handful of qualified suppliers worldwide, lead times are long and demand continues to outpace capacity.
"We are fortunate to be in a strong position," said Jordan Xu. "Our engineering pipeline is full, and the inquiries from India are adding to an already robust order book. But we are disciplined about growth - we would rather serve fewer clients well than overextend ourselves. Quality of partnership matters more to us than quantity of orders."
DROFEN plans to continue expanding its India engagement throughout 2026, with additional client visits, participation in regional industry events, and further investment in local service capabilities.
About DROFEN MACHINERY
DROFEN MACHINERY EQUIPMENT CO., LTD, headquartered in Shanghai, China, specializes in turnkey automation solutions for the pharmaceutical and medical device industries. With roots in non-standard automation dating back to 2009 and a dedicated focus on injectable drug delivery equipment since 2017, DROFEN provides end-to-end solutions covering injection pen pre-assembly, final assembly, prefilled syringe filling, and visual inspection systems. The company serves pharmaceutical manufacturers and CDMOs worldwide.